Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Science › CanopyFit maps urban tree sites with greatest cooling potential
Science

CanopyFit maps urban tree sites with greatest cooling potential

CanopyFit maps urban tree sites with greatest cooling potential
Phys.org Wednesday 26 August 2026, 16:00 UTC 1 min read
Key Points

UBC researchers and municipal partners have developed a modeling tool to help cities adapt to rising temperatures by mapping where new trees offer the greatest cooling impact.

UBC researchers and municipal partners have developed a modeling tool to help cities adapt to rising temperatures by mapping where new trees offer the greatest cooling impact.
UBC (ORG)
Originally published by Phys.org Read original →

Related Stories

Narrow ultrasonic beam enables stable 3D levitation six times farther than before

Scientists have developed a new acoustic levitation technique using an ultrasonic beam capable of levitating and moving small objects in midair over distances of up to 40 cm (16 inches), six times farther than previously achieved using conventional methods. The study, carried out by a research team from the University of Tsukuba in Japan and the University of Bristol, was published in the journal Physical Review Letters.

Phys.org 1h ago

Tax break 'megadeals' spurred innovation in local communities

When cities, counties or states provide corporations with big tax breaks to lure factories, corporate headquarters and other facilities, the economic benefits may go beyond the new jobs and investments the companies bring to their regions.

Phys.org 1h ago

Why some lava-covered exoplanets retain atmospheres for billions of years

Stanford researchers have offered an explanation for why some sizzling, lava-covered worlds nestled tightly around their stars can retain their atmospheres. At such close quarters, intense stellar radiation should strip away a planet's air.

Phys.org 1h ago

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

Daraxonrasib, the first drug of its type, has electrified pancreatic cancer specialists and patients because it has shown it can double life expectancy.

NYT Science 1h ago